Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News GNI Group to halt enrolment in Phase 2 liver fibrosis trial following positive results Japanese biotech company GNI Group has announced it will cease enrolment of new patients in its Phase 2… bypharmanewsdailyOctober 2, 2018